Condition: Endometrial Neoplasms · Endometrial Cancer Stage I · Sentinel Lymph Node · Sponsor: Dokuz Eylul University
This clinical trial evaluates lymph node mapping in newly diagnosed endometrial cancer patients undergoing surgery. The standard technique uses a 2-point methylene blue cervical injection. The study aims to determine if increasing injection points improves mapping success.
This description comes directly from the study's public registry record.
Ibrahim Yalcin, MD · +90 505 265 60 24 · ibrahimyalcin73@gmail.com
Ali Hakan Kula, MD · +905358230685 · hkula95@gmail.com
Always discuss trial participation with your own doctor first.
| Ankara University | Ankara, Turkey (Türkiye) | Recruiting |
| Dokuz Eylul University | Izmir, Turkey (Türkiye) | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07040657